Literature DB >> 10894173

Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907.

H Watabe1, M A Channing, M G Der, H R Adams, E Jagoda, P Herscovitch, W C Eckelman, R E Carson.   

Abstract

The goal of this study was to develop a suitable kinetic analysis method for quantification of 5-HT2A receptor parameters with [11C]MDL 100,907. Twelve control studies and four preblocking studies (400 nmol/kg unlabeled MDL 100,907) were performed in isoflurane-anesthetized rhesus monkeys. The plasma input function was determined from arterial blood samples with metabolite measurements by extraction in ethyl acetate. The preblocking studies showed that a two-tissue compartment model was necessary to fit the time activity curves of all brain regions including the cerebellum--in other words, the need for two compartments is not proof of specific binding. Therefore, a three-tissue compartment model was used to analyze the control studies, with three parameters fixed based on the preblocking data. Reliable fits of control data could be obtained only if no more than three parameters were allowed to vary. For routine use of [11C]MDL 100,907, several simplified methods were evaluated. A two-tissue (2T') compartment with one fixed parameter was the most reliable compartmental approach; a one-compartment model failed to fit the data adequately. The Logan graphical approach was also tested and produced comparable results to the 2T' model. However, a simulation study showed that Logan analysis produced a larger bias at higher noise levels. Thus, the 2T' model is the best choice for analysis of [11C]MDL 100,907 studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894173     DOI: 10.1097/00004647-200006000-00002

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  19 in total

Review 1.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

2.  Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography.

Authors:  Mika Naganawa; Yuichi Kimura; Masahiro Mishina; Yoshitsugu Manabe; Kunihiro Chihara; Keiichi Oda; Kenji Ishii; Kiichi Ishiwata
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

3.  Improved models for plasma radiometabolite correction and their impact on kinetic quantification in PET studies.

Authors:  Matteo Tonietto; Mattia Veronese; Gaia Rizzo; Paolo Zanotti-Fregonara; Talakad G Lohith; Masahiro Fujita; Sami S Zoghbi; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-15       Impact factor: 6.200

4.  First in-human PET study and kinetic evaluation of [18F]AS2471907 for imaging 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Shivani Bhatt; Nabeel B Nabulsi; Songye Li; Zhengxin Cai; David Matuskey; Jason Bini; Soheila Najafzadeh; Michael Kapinos; Jim R Ropchan; Richard E Carson; Kelly P Cosgrove; Yiyun Huang; Ansel T Hillmer
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-21       Impact factor: 6.200

5.  Analysis of 5-HT(2A) receptor binding with [(11)C]MDL 100907 in rats: optimization of kinetic modeling.

Authors:  Anniek K D Visser; Erik F J De Vries; Nisha K Ramakrishnan; Antoon T M Willemsen; Fokko J Bosker; Johan A den Boer; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

6.  Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain.

Authors:  Vasko Kramer; Agnete Dyssegaard; Jonathan Flores; Cristian Soza-Ried; Frank Rösch; Gitte Moos Knudsen; Horacio Amaral; Matthias M Herth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

7.  Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Authors:  Sujata Sridharan; Joel Raffel; Ashwini Nandoskar; Chris Record; David J Brooks; David Owen; David Sharp; Paolo A Muraro; Roger Gunn; Richard Nicholas
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

8.  Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans.

Authors:  Jean-Dominique Gallezot; Nabeel Nabulsi; Alexander Neumeister; Beata Planeta-Wilson; Wendol A Williams; Tarun Singhal; Sunhee Kim; R Paul Maguire; Timothy McCarthy; J James Frost; Yiyun Huang; Yu-Shin Ding; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

9.  Multi-graphical analysis of dynamic PET.

Authors:  Yun Zhou; Weiguo Ye; James R Brasić; Dean F Wong
Journal:  Neuroimage       Date:  2009-11-17       Impact factor: 6.556

10.  Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV.

Authors:  Dianne E Lee; William C Reid; Wael G Ibrahim; Kristin L Peterson; Margaret R Lentz; Dragan Maric; Peter L Choyke; Elaine M Jagoda; Dima A Hammoud
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.